SEARCH · Search PubMed
Results for “Chlorquinaldol”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Prevention of puerperal mastitis by afungil.
Explore the source record for details and available documents.
Allergic contact dermatitis to methyl and propyl paraben.
Explore the source record for details and available documents.
[Elaboration of the method of obtaining aerosols containing vioform and chlorchinaldin, and their clinical evaluation].
Explore the source record for details and available documents.
[Assessment of a new combination drug (locoid-c) for the local treatment of inflammatory dermatoses in a dermatological practice (author's transl)].
Explore the source record for details and available documents.
Clinical experiences with a new steroid-antibacterial preparation in the treatment of infected eczema. (A pilot study in twenty-eight patients).
Explore the source record for details and available documents.
Local antiseptics versus antibiotics in topical therapy--the emergence of microbial resistance.
Explore the source record for details and available documents.
[The therapeutic potentials of the vaginal antimicrobial preparation Chlorchinaldin].
The aim of this study is the clinical testing of the vaginal wide-range, antimicrobial, quinolone--Chlorchinaldin/0,2/by POLFA, which has a strong antibacterial, antifungal, trichomonal and keratoplastic effect. The medicine was used on 43 patients with complaints of aggravated fluor. The clinical, colposcopic and microbiologic study showed: candidiasis--in 16 trichomoniasis--in 8, bacterial vaginalis--in 3 and anaerobic vaginitis--in 2 patients. The rest of the women (14) had various aerobic microbial findings. The treatment was daily using one vaginal tablet, every night for 10 days. A control examination was carried out one week after the any of therapy. The results showed a positive clinical effect, since in 67.4% there were negative microbiological findings. The lack of effect in cases with bacterial vaginosis and anaerobic vaginitis was painted out. These results give reason to believe that the wide antimicrobial range of Chlorchinaldin B will be complementary to the currently used drugs in the treatment of vaginal infections.
[Use of afungil, gioxizone, butadiene and depersolone in treatment of certain dermatoses].
Explore the source record for details and available documents.